FINWIRES · TerminalLIVE
FINWIRES

Syntholene Energy Announces DTC Eligibility

-- Syntholene Energy (ESAF.V) received approval from The Depository Trust Company (DTC) for electronic clearing and settlement of its common shares in the United States, the company said early Friday.

The company's common shares, trading under the ticker symbol "SYNTF" on the OTCQB Venture Market, are now eligible to be electronically cleared and settled through DTC, said the company.

Its common shares will continue to trade on the TSX Venture Exchange under the symbol "ESAF" and on the Frankfurt Stock Exchange under the symbol "3DD0", the company added.

"DTC eligibility represents reduced friction and strengthening of the company's capital markets infrastructure as we expand engagement with U.S. investors," said CEO Dan Sutton. "This milestone supports improved market accessibility and positions Syntholene to broaden its shareholder base as we advance the construction of our Demonstration Facility in Iceland and other development initiatives."

The company's shares were last seen up $0.01 at $0.69 on the TSX Venture Exchange.

Price: $0.69, Change: $+0.01, Percent Change: +1.47%

Related Articles

Research

Research Alert: CFRA Raises Rating On West Pharmaceutical Services, Inc. To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price is $350, up from $267 and represents 41x our 2026 EPS estimate (up $0.63 to $8.53; 2027's up $0.61 to $9.42), near WST's five-year forward average of 42x. Our valuation reflects our view of the strength of the High-Value Products (HVP) business, as well as a growing market for GLP-1 elastomer sales and significant balance sheet health (negative net debt). We anticipate new drug development will support the HVP business, as biologics made up around 42% of sales during Q1 2026. Further, GLP-1 drug demand may provide a new catalyst for sales of syringes. WST secured a multiyear contract with Novo Nordisk for all its GLP-1 primary packaging elastomer needs, and GLP-1 elastomers comprised 10% of Q1 2026 sales. Combined with sales in the West Vantage segment, GLP-1 exposure made up 18% of total net sales during the quarter. The Annex 1 regulatory updates for medical manufacturing also provide tailwinds for HVP via quality upgrade projects for existing WST components, in our view.

$WST
Insider Trading

Goldman Sachs Group Insider Sold Shares Worth $1,044,782, According to a Recent SEC Filing

Alex S Golten, Chief Risk Officer, on April 23, 2026, sold 1,116 shares in Goldman Sachs Group (GS) for $1,044,782. Following the Form 4 filing with the SEC, Golten has control over a total of 2,578 common shares of the company, with 2,578 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886982/000205084926000015/xslF345X05/wk-form4_1777061036.xml

$GS
Australia

Sector Update: Energy Stocks Softer Late Afternoon

Energy stocks declined late Friday afternoon, with the NYSE Energy Sector Index shedding 0.7% and the State Street Energy Select Sector SPDR ETF (XLE) decreasing 0.2%.The Philadelphia Oil Service Sector Index rose 1.8%, and the Dow Jones US Utilities Index added 0.1%.West Texas Intermediate crude oil fell 1.2% to $94.68 a barrel, and global benchmark Brent rose 0.5% to $105.64 a barrel. Henry Hub natural gas futures shed 3.7% to $2.52 per 1 million BTU.In corporate news, TotalEnergies (TTE) secured financing for its Mirny onshore wind and battery energy storage system project in southeast Kazakhstan. The stock fell 0.7%.X-Energy (XE) shares jumped 27% following their debut on Nasdaq.SLB (SLB) reported mixed Q1 results, reflecting headwinds from the Middle East conflict. The shares rose 2.8% as revenue topped estimates, while earnings fell.BP (BP) and Repsol have been accused of anti-competitive practices in a complaint filed with the European Commission by Spanish fuel wholesaler Hatta Energy, Bloomberg reported. BP shares were down 0.4%.

$BP$SLB$TTE$XE